Mitsuru Adachi
- Effects of formoterol-budesonide combination on residual eosinophilic inflammation in distal airway of patients with well-controlled moderate asthmaBy Hiroyuki Ohbayasshi, Naohiro Shibata and Mitsuru AdachiHiroyuki OhbayasshiNaohiro Shibata1Department of Allergy and Respiratory Medicine, Tohno-Kousei Hospital, Mizunami, Gifu, JapanMitsuru Adachi2Department of Respiratory and Allergy Medicine, Showa University, Tokyo, Japan
- Pretreatment with inhaled procaterol improves symptoms of dyspnea and quality of life in patients with severe COPDBy Hiroyuki Ohbayashi and Mitsuru AdachiHiroyuki Ohbayashi1Department of Allergy and Respiratory Medicine, Tohno-Chuo Clinic, Mizunami, Gifu, Japan2Department of Respiratory and Allergy Medicine, Showa University, Tokyo, JapanMitsuru Adachi2Department of Respiratory and Allergy Medicine, Showa University, Tokyo, Japan
- Preventive effect of carbocysteine on exacerbation of asthma, GAIA randomised, placebo-controlled multi-centre studyBy Hiroyuki Sano, Yuji Tohda, Mitsuru Adachi, Takeshi Fukuda, Ken Ohta, Shunsuke Shoji and Terumasa MiyamotoHiroyuki Sano1Department of Respiratory Medicine and Allergology, Kinki University Faculty of Medicine, Osaka-Sayma, JapanYuji Tohda1Department of Respiratory Medicine and Allergology, Kinki University Faculty of Medicine, Osaka-Sayma, JapanMitsuru Adachi2Division of Respiratory Medicine and Allergology, Department of Internal Medicine, Showa University School of Medicine, Tokyo, JapanTakeshi Fukuda3Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Mibu, JapanKen Ohta4Division of Respiratory Medicine & Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, JapanShunsuke Shoji5Clinical Department, National Hospital Organization Tokyo National Hospital, Kiyose, JapanTerumasa Miyamoto6Internal Medicine and Allergology, Japan Clinical Allergy Research Institute, Tokyo, Japan
- Sputum neutrophil monitoring is useful for long-term oxygen therapy in patients with COPDBy Masahide Miyamoto, Ken Takao, Yohko Okada, Minako Maruyama, Eri Tsurugai, Yohko Nakazato and Mitsuru AdachiMasahide Miyamoto1Respiratory Medicine, IMS Group, Ohta Fukushima General Hospital, Ohta City, Japan2Respiratory Medicine and Allergology, Showa University Hospital, JapanKen Takao1Respiratory Medicine, IMS Group, Ohta Fukushima General Hospital, Ohta City, JapanYohko Okada1Respiratory Medicine, IMS Group, Ohta Fukushima General Hospital, Ohta City, JapanMinako Maruyama1Respiratory Medicine, IMS Group, Ohta Fukushima General Hospital, Ohta City, JapanEri Tsurugai1Respiratory Medicine, IMS Group, Ohta Fukushima General Hospital, Ohta City, JapanYohko Nakazato1Respiratory Medicine, IMS Group, Ohta Fukushima General Hospital, Ohta City, JapanMitsuru Adachi1Respiratory Medicine, IMS Group, Ohta Fukushima General Hospital, Ohta City, Japan2Respiratory Medicine and Allergology, Showa University Hospital, Japan
- Improved effects of formoterol-budesonide combination on residual eosinophilic inflammation in asthmatic peripheral airwayBy Hiroyuki Ohbayashi and Mitsuru AdachiHiroyuki Ohbayashi1Department of Allergy and Respiratory Medicine, Tohno-Chuo-Clinic, Mizunami, Gifu, JapanMitsuru Adachi2Department of Medicine, Sanno Hospital, International University of Health and Welfare, Tokyo, Japan
- Interim analysis of post-marketing surveillance of omalizumab in JapanBy Ken Ohta, Hajime Yoshisue, Yasuo Aoki, Takuro Irokawa, Masahide Ishigaki, Mitsuru Adachi and Terumasa MiyamotoKen Ohta1Respiratory Medicine and Allergology, Tokyo National Hospital Organization, Tokyo, JapanHajime Yoshisue2Development, Novartis Pharma K.K., Tokyo, JapanYasuo Aoki2Development, Novartis Pharma K.K., Tokyo, JapanTakuro Irokawa2Development, Novartis Pharma K.K., Tokyo, JapanMasahide Ishigaki2Development, Novartis Pharma K.K., Tokyo, JapanMitsuru Adachi3Clinical Allergy, International Univ. Health & Welfare, Tokyo, JapanTerumasa Miyamoto4Clinical Allergy, Clinical Allergy Institute, Tokyo, Japan
- Factors influencing to HRQOL of patients with mild to moderate persistent asthma in Japan; sub-analysis of GAIA studyBy Kumiya Sugiyama, Takeshi Fukuda, Mitsuru Adachi, Ken Ohta, Yuji Tohda, Shunsuke Shoji and Terumasa MiyamotoKumiya Sugiyama1Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Mibu, JapanTakeshi Fukuda1Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Mibu, JapanMitsuru Adachi2Division of Clinical Allergy, International University of Health and Welfare, Tokyo, JapanKen Ohta3Department of Allergy, National Hospital Organization Tokyo National Hospital, Kiyose, JapanYuji Tohda4Department of Respiratory Medicine and Allergology, Kinki University Faculty of Medicine, Osakasayama, JapanShunsuke Shoji3Department of Allergy, National Hospital Organization Tokyo National Hospital, Kiyose, JapanTerumasa Miyamoto5Internal Medicine and Allergology, Japan Clinical Allergy Research Institute, Tokyo, Japan
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.